Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neema P Mayor

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
HLA|March 21, 2025
The Case of a Missing HLA-B GeneNoah Cline, Dario Merlo, Sandra Frater, et al.
HLA|April 1, 2020
Single molecule real-time DNA sequencing of the full HLA-E gene for 212 reference cell linesJonathan A M Lucas, James D Hayhurst, Thomas R Turner, et al.
Iscience|March 2, 2026
Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised hostJosé Afonso Guerra-Assunção, Ruairi McErlean, Katie Townsend, et al.
The Lancet. Haematology|December 5, 2024
The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experienceNeema P Mayor, Richard M Szydlo, Yasmin Sheikh, et al.
Ejhaem|February 2, 2026
A Pilot Project to Evaluate the Benefit of Additional Support in Haematopoietic Cell Transplant (HCT) Research Data Management on Behalf of Anthony Nolan and BSBMTCTShelley Hewerdine, Greg Judge, Julia Lee, et al.
Plos One|May 29, 2015
HLA Typing for the Next GenerationNeema P Mayor, James Robinson, Alasdair J M McWhinnie, et al.
Haematologica|November 28, 2015
Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsEsteban Arrieta-Bolaños, Neema P Mayor, Steven G E Marsh, et al.
HLA|January 30, 2022
Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell linesThomas R Turner, Daniel R Hayward, Arthur W Gymer, et al.
Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.
Genome Medicine|December 17, 2015
A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantationDirk S Paul, Allison Jones, Rob S Sellar, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
HLA|March 21, 2025
The Case of a Missing HLA-B GeneNoah Cline, Dario Merlo, Sandra Frater, et al.
HLA|April 1, 2020
Single molecule real-time DNA sequencing of the full HLA-E gene for 212 reference cell linesJonathan A M Lucas, James D Hayhurst, Thomas R Turner, et al.
Iscience|March 2, 2026
Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised hostJosé Afonso Guerra-Assunção, Ruairi McErlean, Katie Townsend, et al.
The Lancet. Haematology|December 5, 2024
The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experienceNeema P Mayor, Richard M Szydlo, Yasmin Sheikh, et al.
Ejhaem|February 2, 2026
A Pilot Project to Evaluate the Benefit of Additional Support in Haematopoietic Cell Transplant (HCT) Research Data Management on Behalf of Anthony Nolan and BSBMTCTShelley Hewerdine, Greg Judge, Julia Lee, et al.
Plos One|May 29, 2015
HLA Typing for the Next GenerationNeema P Mayor, James Robinson, Alasdair J M McWhinnie, et al.
Haematologica|November 28, 2015
Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsEsteban Arrieta-Bolaños, Neema P Mayor, Steven G E Marsh, et al.
HLA|January 30, 2022
Widespread non-coding polymorphism in HLA class II genes of International HLA and Immunogenetics Workshop cell linesThomas R Turner, Daniel R Hayward, Arthur W Gymer, et al.
Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.
Genome Medicine|December 17, 2015
A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantationDirk S Paul, Allison Jones, Rob S Sellar, et al.
Pageof 5